Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Research activity includes early breast cancer, invasive breast cancer in early stages, and patients with node-positive disease requiring decisions about adjuvant treatment. The sponsor also works in neoadjuvant therapy for intermediate- and high-risk disease, with attention to treatment selection before surgery and subsequent adjuvant endocrine therapy.

• Hormone receptor-positive early-stage disease
• Node-positive breast cancer
• Recurrence Score-guided treatment decisions

Clinical interest extends to long-term follow-up after early-stage treatment, including patterns of first relapse and outcomes after neoadjuvant and adjuvant care.